作者：
Antonio,Valentin [1]
;
Katherine,McKinnon [2]
;
Jinyao,Li [1]
;
Margherita,Rosati [1]
;
Viraj,Kulkarni [3]
;
Guy R,Pilkington [3]
;
Jenifer,Bear [3]
;
Candido,Alicea [3]
;
Diego A,Vargas-Inchaustegui [4]
;
L,Jean Patterson [4]
;
Poonam,Pegu [5]
;
Namal P M,Liyanage [5]
;
Shari N,Gordon [5]
;
Monica,Vaccari [5]
;
Yichuan,Wang [6]
;
Alison E,Hogg [6]
;
Blake,Frey [6]
;
Yongjun,Sui [6]
;
Steven G,Reed [7]
;
Niranjan Y,Sardesai [8]
;
Jay A,Berzofsky [6]
;
Genoveffa,Franchini [5]
;
Marjorie,Robert-Guroff [4]
;
Barbara K,Felber [9]
;
George N,Pavlakis [10]
作者单位：
Human Retrovirus Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD, USA.
[1]
FACS Core Facility, Vaccine Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
[2]
Human Retrovirus Pathogenesis Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute, Frederick, MD, USA.
[3]
Immune Biology of Retroviral Infection Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, USA.
[4]
Animal Models and Retroviral Vaccine Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, USA.
[5]
Molecular Immunogenetics and Vaccine Research Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, USA.
[6]
Infectious Diseases Research Institute, Seattle, WA, USA.
[7]
Inovio Pharmaceuticals, Inc., Blue Bell, PA, USA.
[8]
Human Retrovirus Pathogenesis Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute, Frederick, MD, USA. Electronic address: Barbara.felber@nih.gov.
[9]
Human Retrovirus Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD, USA. Electronic address: george.pavlakis@nih.gov.
[10]
DOI
10.1016/j.clim.2014.09.005
PMID
25229164
发布时间
2021-10-21
换一批
换一批
